• Careers
  • Investigator Login
Candel Therapeutics
  • About
  • Platforms
  • Pipeline
  • Patients
  • News
  • Contact
  • Menu Menu

Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments

Press Release
/wp-content/uploads/candel_logo.svg 0 0 David Anderson /wp-content/uploads/candel_logo.svg David Anderson2020-12-08 08:00:532020-12-08 08:00:53Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments

Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

Press Release
/wp-content/uploads/candel_logo.svg 0 0 David Anderson /wp-content/uploads/candel_logo.svg David Anderson2020-05-30 08:00:392020-05-30 08:00:39Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting

Press Release
/wp-content/uploads/candel_logo.svg 0 0 David Anderson /wp-content/uploads/candel_logo.svg David Anderson2020-05-18 08:00:012020-05-18 08:00:01Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting

​Candel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise

Press Release
/wp-content/uploads/candel_logo.svg 0 0 David Anderson /wp-content/uploads/candel_logo.svg David Anderson2020-01-08 08:00:542020-01-08 08:00:54​Candel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise
© 2021 by Candel Therapeutics
Scroll to top